Long-term outcomes of pneumococcal meningitis in childhood and adolescence

Deborah Christie1, Russell M Viner, Kyle Knox

  • 1General and Adolescent Paediatrics Unit, UCL Institute of Child Health, London, UK. Deborah.Christie@uclh.nhs.uk

Insights

Pneumococcal meningitis (PM) significantly impacts children's cognitive, educational, and psychological development, leading to long-term sequelae. These findings support the routine use of the pneumococcal conjugate vaccine for children.

Area of Science:

  • Neurology
  • Pediatrics
  • Public Health

Background:

  • Pneumococcal meningitis (PM) can cause long-term adverse outcomes in children.
  • Contemporary data on these sequelae are limited, hindering cost-effectiveness analyses for new vaccines.
  • A vaccine to prevent PM has been introduced, necessitating evidence for its routine use.

Purpose of the Study:

  • To examine the cognitive, educational, psychological, and social outcomes of childhood pneumococcal meningitis.
  • To provide data for cost-effectiveness analyses and inform policy on routine childhood vaccination.

Main Methods:

  • A population-based case-control study was conducted in two UK regions.
  • Children diagnosed with PM (cases) were compared with siblings or neighbours (controls).
  • Assessments included IQ, educational attainment, quality of life, and psychological well-being via questionnaires and neuropsychological testing.

Main Results:

  • 14% of PM patients experienced hearing impairment compared to 1% of controls.
  • Patients showed significantly lower IQ, educational attainment, quality of life, and psychosocial functioning.
  • Parent-reported outcomes indicated greater functional disability and psychological difficulties in patients.

Conclusions:

  • Pneumococcal meningitis is associated with significant and lasting adverse outcomes in children.
  • These sequelae underscore the importance of preventative measures.
  • Findings strongly support the international introduction of the pneumococcal conjugate vaccine into routine childhood immunization schedules.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...